Print Page   |   Sign In   |   Register
Blog Home All Blogs
Search all posts for:   


View all (131) posts »

Stock Market Manager Weekly Update: January 2nd, 2019

Posted By Administration, Friday, January 4, 2019

SMM Logo





Weekly Update: January 2nd, 2019








Latest Happenings

Here is wishing everyone a healthy and prosperous New Year!


A lot more coming in 2019 and we will be publishing the Trickle Model Portfolio 2018 results in the Black Swan Newsletter on the 15th.

Hope you’re holding your breath because we are entering a new world in terms of market volatility. Seems like any cases of the flu with a big name the markets get a daily dose of pneumonia.

Latest hiccup from Apple.

Stocks tank as Apple flashes warning signs

U.S. stocks slid after Apple (AAPL) lowered its outlook for fiscal first quarter 2019 revenue, validating concerns of deteriorating demand for flagship products from one of the country’s largest tech companies and propelling worries of a global growth slowdown.

The S&P 500 (^GSPC) fell 1.83%, or 45.98 points, as of 2:28 p.m. ET. The Dow (^DJI) slid 2.23%, or 515.81 points, while the Nasdaq (^IXIC) declined 2.27%, or 151.52 points. 

Any moves in Apple’s stock contribute heavily to shifts in the three major indices. Apple makes up nearly 10% of the tech-heavy Nasdaq and 3.4% of the S&P 500. And every $1 loss in Apple’s share price contributes to an about 6.8-point decline on the price-weighted Dow – as well as a $4.75 billion reduction in Apple’s market capitalization.

Read Complete Article


Canbiola, Inc. (OTCQB: CANB)
Press Release 12-24-18

Canbiola, Inc. Expects Strong Revenue Growth from Q3 to Q4 2018 as President Trump Signs Farm Bill Legalizing Hemp CBD Nationwide

HICKSVILLE, NY, Dec. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Based upon a strong product demand, Canbiola (OTCQB: CANB) is on the path toward significant revenue growth. The Company has made significant investment in development of its nationwide distribution infrastructure through Its doctor and medical office network and expects this forward movement to continue.  This trend is even potentially more impactful with President Trump signing of the 2018 Farm Bill.   The 2018 Farm Bill removed CBD derived hemp from the Schedule 1 drug list and makes hemp CBD Federally legal for use, interstate transporting, and export.   Hemp based CBD with under .3% THC (the psychoactive ingredient in marijuana) has proven to be medically beneficial in a regimen of wellness and pain relief programs. 

“We believe we are in the right place at the right time with our public company offering a variety of CBD products under our proprietary formulation from the laboratory and production facility in Washington State,” states Canbiola’s CEO, Marco Alfonsi. “We have previously made several announcements regarding our growing number of doctors on our Medical Advisory board as well as our Corporate Advisory Board and with their guidance and some specialty production equipment in the WA facility, we expect to announce numerous new product opportunities.”  

According to a new article from Rolling Stone, The CBD market is expected to grow to $22 billion by 2022, see

From the Rolling Stone article: “CBD, a non-psychoactive cannabinoid found in cannabis, has had a surge in popularity over the past couple of years. Unlike THC, the chemical compound that gives weed its signature effect, CBD has been shown to help with everything from PTSD and anxiety to MS and epilepsy — without getting you high.”

Mr. Alfonsi concludes, “2019 is positioned to be a banner year for Canbiola as we have many new efforts underway and believe these efforts and investments will bear fruit. Canbiola’s entire product offering is 100% Federally legal.”

The Canbiola  family wishes everyone a happy holiday and a healthy and safe New Year.

About Canbiola, Inc.:

Canbiola, Inc. is a public company trading under symbol CANB.

Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. The company has already launched several products found at

Canbiola Investor Relations
Phone: (516) 595-9544
Follow us on Twitter and Facebook



Echelon Wealth Partners
Research Update 11-11-18
Antibe Therapeutics (TSXV-ATE)
Speculative Buy Target Price $1.40

Event: Ontario-based drug developer Antibe Therapeutics reported FQ219 financial data for the Sept-end quarter that met our expectations on most income statement metrics and on development timelines for flagship hydrogen sulfide-releasing naproxen analog ATB-346, as we will describe below. Bottom line:We are maintaining our Speculative BUY rating and $1.40 PT on ATE, with our valuation still based on NPV (40% discount rate) and multiples of our F2025 adjusted EBITDA/EPS forecasts ($165.6M/$0.41, respectively), with both profitability metrics driven by our expectations that ATB-346 can perform well in future Phase III knee osteoarthritis pain studies and that pending performance in the soon-to-commence 200-250-patient Phase II knee osteoarthritis will be sufficiently positive on key efficacy measures (WOMAC-based pain relief with simultaneous reduction in incidence/severity of gastroduodenal ulcers) to justify advancing into future pivotal studies and to support FDA approval/launch and “partnerability”. At current levels, our PT corresponds to a one-year return of 418%.

Read Complete Report

*Echelon is a leading independent, Canadian-owned and operated wealth management and capital markets firm. While SMM has no relationship with Echelon and is not being compensated for distribution of these research reports, Owners of SMM are significant shareholders in Antibe Holding which in turn has a significant interest in Antibe Therapeutics, Inc.

Trickle Research
Earnings Update 12-3-18
Summit Wireless Technologies, Inc. (WISA)
12-24 Month Target Price $9.25

There is not a great deal to update here since we just initiated the coverage near the end of this reporting period. As we noted in the initial coverage, we are not expecting much from the numbers for the second half, which of curse includes this reporting period and the one we are currently in. For what it is worth, the numbers were largely in lie. SG&A was a bit higher than we anticipated, but given the IPO in the quarter, as well as several other restructuring items (debt conversions etc.), we suspect that line item was particularly extraordinary.

Click Here for Report


Trickle Research Earnings Update 11-28-18
Social Reality, Inc. (SRAX)
12-24 Month Target Price $8.50

SRAX reported their 3QF18 results the other day, but with the holiday stuck between here and there, we are just catching up. Frankly there were no surprises of note. Recall, in some of our prior writings, we noted that the SRAXmd sale would “muddy” the Q3 numbers with extraordinary items. As it turned out, the numbers included about 37 days of SRAXmd contributions, which added to the extraordinariness. O

Click Here for Report

Trickle Research Earnings Update 11-13-18
Command Center, Inc. (CCNI)
12-24 Month Target Price $8.75

We have been covering CCNI for some time now, and we must admit, we seem to have a hard time nailing down the numbers one quarter to the next. After last quarter, we noted that we were “paring back some of our estimates just to try to get them more in line with the results over the past few quarters where revenue comps have been flat”. However, as it turned out, they reported revenues of $26.3 million which was just over $760,000 or about 3% higher than our revised estimate. The $26.3 million was about ½ way between the Q1 estimate we revised down, and the new number we revised down to.

Click Here for Report


New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.


Jan 3-19









(listing, quotes, news, research)







Aethlon Medical, Inc. (AEMD)





Alvopetro Energy, Ltd. (ALVOF)





Assure Holdings, Inc. (ARHH)





Antibe Therapeutics, Inc (ATBPF)





AzuerRx Biopharma, Inc. (AZRX)




Camino Minerals Corp. (CAMZF)




Canbiola, Inc. (CANB)




News, Inc. (CIIX)




Clean Coal Technologies, Inc (CCTC)




Command Center , Inc. (CCNI)





Endurance Exploration Group, Ltd (EXPL)





Ecom Products Group (EPGC)









Galaxy Gaming, Inc. (GLXZ)





Guangdong Land Holdings Limited (124) HK



Magnegas, Inc. (MNGA)





MOBI724 Global Solutions, Inc. (MOBIF)




New Jersey Mining Company (NJMC)




Petroshare Corp. (PRHR)





Summit Wireless Technologies, Inc.





Social Reality, Inc. (SRAX)





Zynex, Inc. (ZYXI)








January 3rd, 2019

ValuEngine Stock Pick of the Day - January 3rd CryoPort, Inc. (CYRX) Last Close : $9.47 ValuEngine Forecast Model Expected Returns: For Complete Report
Click HERE


VALUATION WATCH: Overvalued stocks now make up 21.32% of our stocks assigned a valuation and 7.44% of those equities are calculated to be overvalued by 20% or more. Twelve sectors are calculated to be overvalued.  

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners


Black Swan Research Coverage and Subscription Service
Click Here>>


Event Calendar Updates

March 25-26
Crowne Plaza Time Square
New York City

The National Investment Banking Association (NIBA) is proud to host its 146th investment conference on March 25-26, 2019 at the Crowne Plaza Times Square in New York City.

Check it Out and Register

LD Micro   
December 4-6

Luxe Sunset | Bel-Air, CA
Click Here for Info

Awesome turnout at LD Micro. After the problems with fires etc this turned out terrific in spite of some inclement weather. Hats off to Chris and his team!!

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage


-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)       1,414

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6

SMM Instagram                      (followers)                             131         

Direct Email                                                                  345,000

Total                                                                             353,485




This post has not been tagged.

Share |
Permalink | Comments (0)
Community Search
Sign In